Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Semaglutide biosimilar by Leto Laboratories for Diabetes: Likelihood of Approval
Semaglutide biosimilar is under clinical development by Leto Laboratories and currently in Phase II for Diabetes. According to GlobalData, Phase...